ESC Premium Access

Impact of caval vein implantation on severity of tricuspid regurgitation, renal and hepatic function in patients with severe secondary tricuspid regurgitation

Congress Presentation

About the speaker

Doctor Isabel Mattig

Charite University Hospital, Berlin (Germany)
1 presentation
0 follower

6 more presentations in this session

Impact of left atrial diameter on outcome in patients undergoing edge-to-edge mitral valve repair: results from the german TRAnscatheter Mitral valve Interventions registry (TRAMI)

Speaker: Doctor C. Iliadis (Cologne, DE)


Impact of tricuspid valve regurgitation severity and its secondary reduction on long-term survival after transcatheter mitral valve edge-to-edge repair

Speaker: Doctor M. Geyer (Mainz, DE)


Use of MitraClip system for severe mitral regurgitation in cardiogenic shock: results from a multicentre observational Italian experience (the MITRA-SHOCK study)

Speaker: Doctor G. Falasconi (Milan, IT)


Impact of right ventricular volume and function assessed by cardiac magnetic resonance imaging on outcomes in patients undergoing MitraClip implantation

Speaker: Doctor M. Spieker (Duesseldorf, DE)


Transseptal transcatheter mitral valve implantation versus redo surgical mitral valve replacement for degenerated mitral bioprostheses

Speaker: Doctor A. Fuchs (Paris, FR)


Access the full session

Novelty in Percutaneous Mitral and Tricuspid Valve Interventions

Speakers: Doctor I. Mattig, Doctor C. Iliadis, Doctor M. Geyer, Doctor G. Falasconi, Doctor M. Spieker...

About the event


ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb